Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for FREE ACCESS to this landmark database

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Journal of Child Neurology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Murakami, K.
Right arrow Articles by Kobayashi, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Murakami, K.
Right arrow Articles by Kobayashi, Y.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Alterations of Urinary Acetylcarnitine in Valproate-Treated Rats: The Effect of L-Carnitine Supplementation

Kiyotaka Murakami, MD

Department of Pediatrics, Kansai Medical University, Fumizonocho 1, Moriguchi, Osaka 570, Japan

Tateo Sugimoto, MD

Department of Pediatrics, Kansai Medical University, Fumizonocho 1, Moriguchi, Osaka 570, Japan

Naoki Nishida, MD

Department of Pediatrics, Kansai Medical University, Fumizonocho 1, Moriguchi, Osaka 570, Japan

Man Woo, MD

Department of Pediatrics, Kansai Medical University, Fumizonocho 1, Moriguchi, Osaka 570, Japan

Atsushi Araki, MD

Department of Pediatrics, Kansai Medical University, Fumizonocho 1, Moriguchi, Osaka 570, Japan

Yohnosuke Kobayashi, MD

Department of Pediatrics, Kansai Medical University, Fumizonocho 1, Moriguchi, Osaka 570, Japan

Urinary excretion of acetylcarnitine was measured by high-performance liquid chromatography in two experimental groups of valproate-treated rats. In the urine of mature rats weighing 180 to 200 g treated with valproate (500 mg/kg/day), acetylcarnitine levels were higher than those in controls on days 4 and 7, while L-carnitine-supplemented rats showed lower levels than the valproate group. The valproate-treated rats showed an increased acetylcarnitine/acylcarnitine ratio on and after day 4, while the L-carnitine-supplemented rats showed no significant change compared to the controls on any days. In the urine of immature rats weighing 80 to 90 g treated with valproate (50 mg/kg/day), acetylcarnitine levels were increased after the 14th day of treatment.

These results suggest that an increase in urinary acetylcarnitine occurs when small doses of valproate are administered for a longer time. We speculate that increased acetylcarnitine is not a product of β-oxidation in mitochondria, because L-carnitine supplementation decreases the acetylcarnitine levels. Although the mechanism of acetylcarnitine excretion during valproate administration is not clear, L-carnitine supplementation is effective in decreasing the level of urinary acetylcarnitine and keeping the acetylcarnitine/acylcarnitine ratio normal. (J Child Neurol 1992;7:404-407).

Journal of Child Neurology, Vol. 7, No. 4, 404-407 (1992)
DOI: 10.1177/088307389200700414


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?